Hayley Virgil
Articles
Liso-cel Exhibits Durable Responses in Relapsed-Refractory Large B-Cell Lymphoma
April 27, 2022
Article
Patients with relapsed/refractory large B-cell lymphoma continued to derive benefit from lisocabtagene maraleucel after 2 years of follow-up.
Axi-cel Sustains Long-Term Survival Rates in Relapsed/Refractory Large B-Cell Lymphoma
April 26, 2022
Article
Patients with relapsed or refractory large B-cell lymphoma experienced improved overall survival following treatment with axicabtagene ciloleucel.
Maintenance Selinexor Yields Survival Benefit in Advanced or Recurrent Endometrial Cancer
March 23, 2022
Article
Selinexor demonstrated impressive efficacy in extending progression-free survival among patient with advanced or recurrent endometrial cancer, particularly among patients with wild-type p53 endometrial cancer.
Pembrolizumab Plus Sacituzumab Govitecan Yields Encouraging Antitumor Activity in Metastatic Urothelial Cancer
February 22, 2022
Article
Adding sacituzumab govitecan to second-line pembrolizumab garnered promising antitumor activity among patients with checkpoint inhibitor–naïve metastatic urothelial cancer.
Genomic Alterations in Primary Breast Cancer May Increase Risk of Secondary Uterine Cancer in Patients Receiving Tamoxifen
December 31, 2021
Article
PI3K-pathway mutations may predict an increased risk of secondary uterine cancer in patients receiving tamoxifen to treat primary breast cancer.
Low-Dose Venetoclax Induces Antitumor Activity in Subsets of AL Amyloidosis, Myeloma
August 11, 2021
Article
Overall, 71% of patients with AL amyloidosis and 33% of those with heavily pretreated multiple myeloma achieved a partial response or greater after receiving treatment with low dose venetoclax.
African Ancestry Associated With Increased Prostate Cancer Risk
August 09, 2021
Article
Germline variation may cause men of African descent to have a higher risk of prostate than men of European descent.
Visceral Fat Index Score Questions Obesity-Survival Connection in Early-Stage Lung Cancer
August 04, 2021
Article
Whether or not obesity should be considered a risk factor for non-small lung cancer might be determined by how it is measured.
Diverse Patient Population Favors Immediate Therapy After Receiving Genomic Prostate Score
August 02, 2021
Article
Patients with favorable-risk prostate cancer tended to move away from active surveillance to initiating treatment after receiving their Oncotype DX Genomic Prostate Score.
Race, Socioeconomic Factors May Impact Survival Outcome in Limited-Stage Small Cell Lung Cancer
July 31, 2021
Article
African American, Asian, and Hispanic patients with limited-stage small cell lung cancer displayed superior survival outcomes compared with White patients, indicating that race might be linked with survival in this disease.